 | • レポートコード：MRC2012A5630 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、リンパ腫治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。リンパ腫治療薬の種類別市場規模（経口、注射）、用途別市場規模（ホジキンリンパ腫、非ホジキンリンパ腫）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Roche、Abbvie、CHIPSCREEN、Johnson & Johnson、Celgene、 ・地域別グローバル市場分析 2015年-2020年 ・リンパ腫治療薬の北米市場（アメリカ、カナダ、メキシコ） ・リンパ腫治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・リンパ腫治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・リンパ腫治療薬の南米市場（ブラジル、アルゼンチン） ・リンパ腫治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：経口、注射 ・用途別分析：ホジキンリンパ腫、非ホジキンリンパ腫 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Lymphoma Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Lymphoma Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Lymphoma Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Lymphoma Drugs market has been segmented into
Oral
Injection
By Application, Lymphoma Drugs has been segmented into:
Hodgkin Lymphoma
Non-Hodgkin Lymphoma
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Lymphoma Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Lymphoma Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Lymphoma Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Lymphoma Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Lymphoma Drugs Market Share Analysis
Lymphoma Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Lymphoma Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Lymphoma Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Lymphoma Drugs are:
Roche
Abbvie
CHIPSCREEN
Johnson & Johnson
Celgene
Among other players domestic and global, Lymphoma Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Lymphoma Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Lymphoma Drugs, with price, sales, revenue and global market share of Lymphoma Drugs in 2018 and 2019.
Chapter 3, the Lymphoma Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Lymphoma Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Lymphoma Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Lymphoma Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Lymphoma Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Lymphoma Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Oral
1.2.3 Injection
1.3 Market Analysis by Application
1.3.1 Overview: Global Lymphoma Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hodgkin Lymphoma
1.3.3 Non-Hodgkin Lymphoma
1.4 Overview of Global Lymphoma Drugs Market
1.4.1 Global Lymphoma Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche SWOT Analysis
2.1.4 Roche Product and Services
2.1.5 Roche Lymphoma Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Abbvie
2.2.1 Abbvie Details
2.2.2 Abbvie Major Business
2.2.3 Abbvie SWOT Analysis
2.2.4 Abbvie Product and Services
2.2.5 Abbvie Lymphoma Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 CHIPSCREEN
2.3.1 CHIPSCREEN Details
2.3.2 CHIPSCREEN Major Business
2.3.3 CHIPSCREEN SWOT Analysis
2.3.4 CHIPSCREEN Product and Services
2.3.5 CHIPSCREEN Lymphoma Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson SWOT Analysis
2.4.4 Johnson & Johnson Product and Services
2.4.5 Johnson & Johnson Lymphoma Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Celgene
2.5.1 Celgene Details
2.5.2 Celgene Major Business
2.5.3 Celgene SWOT Analysis
2.5.4 Celgene Product and Services
2.5.5 Celgene Lymphoma Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Lymphoma Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Lymphoma Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Lymphoma Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Lymphoma Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Lymphoma Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Lymphoma Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Lymphoma Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Lymphoma Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Lymphoma Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Lymphoma Drugs Sales and Growth Rate (2015-2020)
4.5 South America Lymphoma Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Lymphoma Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Lymphoma Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Lymphoma Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Lymphoma Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Lymphoma Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Lymphoma Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Lymphoma Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Lymphoma Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Lymphoma Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Lymphoma Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Lymphoma Drugs Sales and Growth Rate (2015-2020)
6.3 UK Lymphoma Drugs Sales and Growth Rate (2015-2020)
6.4 France Lymphoma Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Lymphoma Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Lymphoma Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Lymphoma Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Lymphoma Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Lymphoma Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Lymphoma Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Lymphoma Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Lymphoma Drugs Sales and Growth Rate (2015-2020)
7.5 India Lymphoma Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Lymphoma Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Lymphoma Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Lymphoma Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Lymphoma Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Lymphoma Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Lymphoma Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Lymphoma Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Lymphoma Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Lymphoma Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Lymphoma Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Lymphoma Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Lymphoma Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Lymphoma Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Lymphoma Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Lymphoma Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Lymphoma Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Lymphoma Drugs Price by Type (2015-2020)
11 Global Lymphoma Drugs Market Segment by Application
11.1 Global Lymphoma Drugs Sales Market Share by Application (2015-2020)
11.2 Global Lymphoma Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Lymphoma Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Lymphoma Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Lymphoma Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Lymphoma Drugs Market Forecast (2021-2025)
12.2.2 Europe Lymphoma Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Lymphoma Drugs Market Forecast (2021-2025)
12.2.4 South America Lymphoma Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Lymphoma Drugs Market Forecast (2021-2025)
12.3 Lymphoma Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Lymphoma Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Lymphoma Drugs Market Share Forecast by Type (2021-2025)
12.4 Lymphoma Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Lymphoma Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Lymphoma Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Lymphoma Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Lymphoma Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Lymphoma Drugs Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Lymphoma Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Roche Basic Information, Manufacturing Base and Competitors
Table 9. Roche Lymphoma Drugs Major Business
Table 10. Roche Lymphoma Drugs Total Revenue (USD Million) (2018-2019)
Table 11. Roche SWOT Analysis
Table 12. Roche Lymphoma Drugs Product and Services
Table 13. Roche Lymphoma Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Abbvie Basic Information, Manufacturing Base and Competitors
Table 15. Abbvie Lymphoma Drugs Major Business
Table 16. Abbvie Lymphoma Drugs Total Revenue (USD Million) (2018-2019)
Table 17. Abbvie SWOT Analysis
Table 18. Abbvie Lymphoma Drugs Product and Services
Table 19. Abbvie Lymphoma Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. CHIPSCREEN Basic Information, Manufacturing Base and Competitors
Table 21. CHIPSCREEN Lymphoma Drugs Major Business
Table 22. CHIPSCREEN Lymphoma Drugs Total Revenue (USD Million) (2018-2019)
Table 23. CHIPSCREEN SWOT Analysis
Table 24. CHIPSCREEN Lymphoma Drugs Product and Services
Table 25. CHIPSCREEN Lymphoma Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 27. Johnson & Johnson Lymphoma Drugs Major Business
Table 28. Johnson & Johnson Lymphoma Drugs Total Revenue (USD Million) (2018-2019)
Table 29. Johnson & Johnson SWOT Analysis
Table 30. Johnson & Johnson Lymphoma Drugs Product and Services
Table 31. Johnson & Johnson Lymphoma Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Celgene Basic Information, Manufacturing Base and Competitors
Table 33. Celgene Lymphoma Drugs Major Business
Table 34. Celgene Lymphoma Drugs Total Revenue (USD Million) (2018-2019)
Table 35. Celgene SWOT Analysis
Table 36. Celgene Lymphoma Drugs Product and Services
Table 37. Celgene Lymphoma Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Global Lymphoma Drugs Sales by Manufacturer (2018-2019) (K Units)
Table 39. Global Lymphoma Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 40. Global Lymphoma Drugs Sales by Regions (2015-2020) (K Units)
Table 41. Global Lymphoma Drugs Sales Market Share by Regions (2015-2020)
Table 42. Global Lymphoma Drugs Revenue by Regions (2015-2020) (USD Million)
Table 43. North America Lymphoma Drugs Sales by Countries (2015-2020) (K Units)
Table 44. North America Lymphoma Drugs Sales Market Share by Countries (2015-2020)
Table 45. North America Lymphoma Drugs Revenue by Countries (2015-2020) (USD Million)
Table 46. North America Lymphoma Drugs Revenue Market Share by Countries (2015-2020)
Table 47. Europe Lymphoma Drugs Sales by Countries (2015-2020) (K Units)
Table 48. Europe Lymphoma Drugs Sales Market Share by Countries (2015-2020)
Table 49. Europe Lymphoma Drugs Revenue by Countries (2015-2020) (USD Million)
Table 50. Asia-Pacific Lymphoma Drugs Sales by Regions (2015-2020) (K Units)
Table 51. Asia-Pacific Lymphoma Drugs Sales Market Share by Regions (2015-2020)
Table 52. Asia-Pacific Lymphoma Drugs Revenue by Regions (2015-2020) (USD Million)
Table 53. South America Lymphoma Drugs Sales by Countries (2015-2020) (K Units)
Table 54. South America Lymphoma Drugs Sales Market Share by Countries (2015-2020)
Table 55. South America Lymphoma Drugs Revenue by Countries (2015-2020) (USD Million)
Table 56. South America Lymphoma Drugs Revenue Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Lymphoma Drugs Sales by Countries (2015-2020) (K Units)
Table 58. Middle East & Africa Lymphoma Drugs Sales Market Share by Countries (2015-2020)
Table 59. Middle East & Africa Lymphoma Drugs Revenue by Countries (2015-2020) (USD Million)
Table 60. Middle East & Africa Lymphoma Drugs Revenue Market Share by Countries (2015-2020)
Table 61. Global Lymphoma Drugs Sales by Type (2015-2020) (K Units)
Table 62. Global Lymphoma Drugs Sales Share by Type (2015-2020)
Table 63. Global Lymphoma Drugs Revenue by Type (2015-2020) (USD Million)
Table 64. Global Lymphoma Drugs Revenue Share by Type (2015-2020)
Table 65. Global Lymphoma Drugs Sales by Application (2015-2020) (K Units)
Table 66. Global Lymphoma Drugs Sales Share by Application (2015-2020)
Table 67. Global Lymphoma Drugs Sales Forecast by Regions (2021-2025) (K Units)
Table 68. Global Lymphoma Drugs Market Share Forecast by Regions (2021-2025)
Table 69. Global Lymphoma Drugs Sales Forecast by Type (2021-2025) (K Units)
Table 70. Global Lymphoma Drugs Market Share Forecast by Type (2021-2025)
Table 71. Global Lymphoma Drugs Sales Forecast by Application (2021-2025)
Table 72. Global Lymphoma Drugs Market Share Forecast by Application (2021-2025)
Table 73. Direct Channel Pros & Cons
Table 74. Indirect Channel Pros & Cons
Table 75. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Lymphoma Drugs Picture
Figure 2. Global Sales Market Share of Lymphoma Drugs by Type in 2019
Figure 3. Oral Picture
Figure 4. Injection Picture
Figure 5. Lymphoma Drugs Sales Market Share by Application in 2019
Figure 6. Hodgkin Lymphoma Picture
Figure 7. Non-Hodgkin Lymphoma Picture
Figure 8. Global Lymphoma Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Lymphoma Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Lymphoma Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Lymphoma Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Lymphoma Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Lymphoma Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Lymphoma Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Lymphoma Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Lymphoma Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Lymphoma Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Lymphoma Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Lymphoma Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Lymphoma Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Lymphoma Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Lymphoma Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Lymphoma Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Lymphoma Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Lymphoma Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Lymphoma Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Lymphoma Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Lymphoma Drugs Sales Market Share by Manufacturer in 2019
Figure 29. Global Lymphoma Drugs Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Lymphoma Drugs Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Lymphoma Drugs Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Lymphoma Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 34. Global Lymphoma Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Lymphoma Drugs Revenue Market Share by Regions (2015-2020)
Figure 36. Global Lymphoma Drugs Revenue Market Share by Regions in 2018
Figure 37. North America Lymphoma Drugs Sales and Growth Rate (2015-2020)
Figure 38. Europe Lymphoma Drugs Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Lymphoma Drugs Sales and Growth Rate (2015-2020)
Figure 40. South America Lymphoma Drugs Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Lymphoma Drugs Sales and Growth Rate (2015-2020)
Figure 42. North America Lymphoma Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Lymphoma Drugs Sales Market Share by Countries (2015-2020)
Figure 44. North America Lymphoma Drugs Sales Market Share by Countries in 2018
Figure 45. North America Lymphoma Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Lymphoma Drugs Revenue Market Share by Countries in 2018
Figure 47. United States Lymphoma Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 48. Canada Lymphoma Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Mexico Lymphoma Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Europe Lymphoma Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Lymphoma Drugs Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Lymphoma Drugs Revenue Market Share by Countries in 2019
Figure 53. Germany Lymphoma Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 54. UK Lymphoma Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 55. France Lymphoma Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Russia Lymphoma Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Italy Lymphoma Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Asia-Pacific Lymphoma Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Lymphoma Drugs Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Lymphoma Drugs Revenue Market Share by Regions 2019
Figure 61. China Lymphoma Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Japan Lymphoma Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Korea Lymphoma Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 64. India Lymphoma Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Southeast Asia Lymphoma Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 66. South America Lymphoma Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Lymphoma Drugs Sales Market Share by Countries in 2019
Figure 68. South America Lymphoma Drugs Revenue Market Share by Countries in 2019
Figure 69. Brazil Lymphoma Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Lymphoma Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Middle East and Africa Lymphoma Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Lymphoma Drugs Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Lymphoma Drugs Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Lymphoma Drugs Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Lymphoma Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Egypt Lymphoma Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Turkey Lymphoma Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 78. South Africa Lymphoma Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Global Lymphoma Drugs Sales and Growth Rate (2021-2025) (K Units)
Figure 80. Global Lymphoma Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Lymphoma Drugs Market Forecast (2021-2025) (K Units)
Figure 82. Europe Sales Lymphoma Drugs Market Forecast (2021-2025) (K Units)
Figure 83. Asia-Pacific Sales Lymphoma Drugs Market Forecast (2021-2025) (K Units)
Figure 84. South America Sales Lymphoma Drugs Market Forecast (2021-2025) (K Units)
Figure 85. Middle East & Africa Sales Lymphoma Drugs Market Forecast (2021-2025) (K Units)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
非ホジキンリンパ腫（NHL）の世界市場（～2026年） Non-Hodgkin Lymphoma is the most common lymphoma which affects large number of people. It begins in lymphocytes present in lymph nodes of body parts such as neck or chest or under the arms. It widely spreads to the other lymph nodes and to other organs such as bone marrow, lungs, or liver. Market An…- ホジキンリンパ腫治療薬の世界市場（～2026年） Hodgkin's Lymphoma (HL) is defined as the cancer of the lymph tissue, which is part of our immune system. The exact etiology of HL is unknown. However, the risk of developing the condition is increased if a person suffers from a medical condition that weakens the immune system. In HL, cells in the l…
- リンパ芽球性リンパ腫治療薬の世界市場（～2026年） Lymphoblastic lymphoma (LL) is a rare type of fast-growing non-Hodgkin lymphoma (NHL). It develops when the body makes abnormal lymphocytes. It can develop from both B-cell and T-cell lymphocytes. Lymphocytes are white blood cells that fight infection. Market Analysis and Insights: Global Lymphoblas…
- 悪性リンパ腫の世界市場（～2026年） Cancers that start anywhere in the body’s lymphatic system are called lymphomas. If they have the ability to spread, they are called malignant. The lymphatic system runs throughout our bodies and is composed of lymphoid tissue, vessels, and fluid. Lymphoid tissue contains lymph nodes, which are part…
- 濾胞性リンパ腫治療の世界市場（～2026年） Follicular lymphoma is a type of blood cancer. It is the most common of the indolent (slow-growing) non-Hodgkin's lymphomas, and the second-most-common form of non-Hodgkin's lymphomas overall. It is defined as a lymphoma of follicle center B-cells (centrocytes and centroblasts), which has at least a…